← Back to Search

Behavioral Intervention

Army-SPRING for Suicide

Phase 1
Waitlist Available
Led By Ashley Hagaman, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Serving as an SIO or chaplain/religious affairs specialist for a unit of the CTARNG
* Willing to provide informed consent.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, quarterly, year 1, year 2
Awards & highlights

Summary

Every unit in the Connecticut Army National Guard has a Suicide Intervention Officer to provide suicide intervention education awareness for their unit, monitor for soldiers in crisis and connect soldiers with helping resources and agencies. Suicide Intervention Officers need support in this difficult role, yet there is limited guidance on how to help them. This study will shed light on how to support Suicide Intervention Officers and whether this support results in reduced suicide risk in their units.

Who is the study for?
This trial is for Suicide Intervention Officers in the Connecticut Army National Guard. It aims to support them in their role of providing suicide intervention, monitoring soldiers in crisis, and connecting them with resources.
What is being tested?
The study is testing a new support program called Army-SPRING against the current standard practice. The goal is to see if this additional support can help reduce suicide risks within military units.
What are the potential side effects?
Since this trial involves educational and supportive interventions rather than medical treatments, traditional physical side effects are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, quarterly, year 1, year 2
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, quarterly, year 1, year 2 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reach - Buddy
Reach - Interactions with soldiers involving discussions about suicide risk
Reach - Self
Secondary study objectives
Acceptability
Adoption
Appropriateness
+5 more
Other study objectives
Intentions, attitudes, norms
Organizational culture

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Army-SPRINGExperimental Treatment1 Intervention
Army-SPRING includes a package of implementation options to support implementation of ASIST
Group II: Risk Reduction Group (Control)Placebo Group1 Intervention
Risk Reduction Group is a mandated training from National Guard Service members

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,043 Previous Clinical Trials
42,889,570 Total Patients Enrolled
17 Trials studying Suicide
52,838 Patients Enrolled for Suicide
Yale UniversityOTHER
1,890 Previous Clinical Trials
3,016,633 Total Patients Enrolled
7 Trials studying Suicide
455 Patients Enrolled for Suicide
Ashley Hagaman, PhDPrincipal InvestigatorYale University
1 Previous Clinical Trials
36 Total Patients Enrolled
1 Trials studying Suicide
36 Patients Enrolled for Suicide
~38 spots leftby Sep 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top